It is important to distinguish between immunosuppressionwhich impairs the body's defense mechanismsand the metabolic changes associated with weight loss and improved glycemic control
Evidence on outcomes from GLP-1RAs in HFrEF is continuing to evolve
Before the pandemic, Uswatte and Edward Taub, Ph.D., retired University Professor in the Department of Psychology and founding director of the CI Therapy Research Team, had been working on adapting Constraint-Induced Movement Therapy, or CI Therapy, originally developed by Taub, to help with cognitive issues
The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release
This is the first maintenance dose for many patients